Recurrent glioblastoma multiforme

Advances in treatment and promising drug candidates

Lijo Simpson, Evanthia Galanis

Research output: Contribution to journalArticle

27 Citations (Scopus)

Abstract

Recurrent glioblastoma multiforme is a lethal disease with currently available treatment options having a limited impact on outcome. In this article, current and novel therapeutic approaches in the treatment of recurrent glioblastoma multiforme, including chemotherapy, targeted molecular agents, virotherapy/gene therapy and immunotherapy and challenges in developing novel therapeutic agents for glioblastoma multiforme will be discussed.

Original languageEnglish (US)
Pages (from-to)1593-1607
Number of pages15
JournalExpert Review of Anticancer Therapy
Volume6
Issue number11
DOIs
StatePublished - Nov 2006

Fingerprint

Glioblastoma
Pharmaceutical Preparations
Therapeutics
Genetic Therapy
Immunotherapy
Drug Therapy

Keywords

  • Chemotherapy
  • Gene therapy
  • Glioblastoma multiforme
  • Immunotherapy
  • Recurrence
  • Small molecule cell cycle inhibitors

ASJC Scopus subject areas

  • Pharmacology
  • Cancer Research

Cite this

Recurrent glioblastoma multiforme : Advances in treatment and promising drug candidates. / Simpson, Lijo; Galanis, Evanthia.

In: Expert Review of Anticancer Therapy, Vol. 6, No. 11, 11.2006, p. 1593-1607.

Research output: Contribution to journalArticle

@article{0a45a34645e84634b51bf18624c7a6e6,
title = "Recurrent glioblastoma multiforme: Advances in treatment and promising drug candidates",
abstract = "Recurrent glioblastoma multiforme is a lethal disease with currently available treatment options having a limited impact on outcome. In this article, current and novel therapeutic approaches in the treatment of recurrent glioblastoma multiforme, including chemotherapy, targeted molecular agents, virotherapy/gene therapy and immunotherapy and challenges in developing novel therapeutic agents for glioblastoma multiforme will be discussed.",
keywords = "Chemotherapy, Gene therapy, Glioblastoma multiforme, Immunotherapy, Recurrence, Small molecule cell cycle inhibitors",
author = "Lijo Simpson and Evanthia Galanis",
year = "2006",
month = "11",
doi = "10.1586/14737140.6.11.1593",
language = "English (US)",
volume = "6",
pages = "1593--1607",
journal = "Expert Review of Anticancer Therapy",
issn = "1473-7140",
publisher = "Expert Reviews Ltd.",
number = "11",

}

TY - JOUR

T1 - Recurrent glioblastoma multiforme

T2 - Advances in treatment and promising drug candidates

AU - Simpson, Lijo

AU - Galanis, Evanthia

PY - 2006/11

Y1 - 2006/11

N2 - Recurrent glioblastoma multiforme is a lethal disease with currently available treatment options having a limited impact on outcome. In this article, current and novel therapeutic approaches in the treatment of recurrent glioblastoma multiforme, including chemotherapy, targeted molecular agents, virotherapy/gene therapy and immunotherapy and challenges in developing novel therapeutic agents for glioblastoma multiforme will be discussed.

AB - Recurrent glioblastoma multiforme is a lethal disease with currently available treatment options having a limited impact on outcome. In this article, current and novel therapeutic approaches in the treatment of recurrent glioblastoma multiforme, including chemotherapy, targeted molecular agents, virotherapy/gene therapy and immunotherapy and challenges in developing novel therapeutic agents for glioblastoma multiforme will be discussed.

KW - Chemotherapy

KW - Gene therapy

KW - Glioblastoma multiforme

KW - Immunotherapy

KW - Recurrence

KW - Small molecule cell cycle inhibitors

UR - http://www.scopus.com/inward/record.url?scp=33845358505&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=33845358505&partnerID=8YFLogxK

U2 - 10.1586/14737140.6.11.1593

DO - 10.1586/14737140.6.11.1593

M3 - Article

VL - 6

SP - 1593

EP - 1607

JO - Expert Review of Anticancer Therapy

JF - Expert Review of Anticancer Therapy

SN - 1473-7140

IS - 11

ER -